Clinical guidelines

On May 5, 2025, the Belgian Health Care Knowledge Centre (KCE) opened its annual call for topic proposals for the 2026 research program, which includes Clinical Guidelines, Health Technology Assessments, and Health Services Research. Interested stakeholders can submit the proposals by June 30, 2025.

In December 2023, the National Institute for Health and Care Excellence (NICE) published one new Interventional Procedure Guidance (middle meningeal artery embolization for chronic subdural hematomas), one Technology Appraisal Guidance (Hybrid closed loop systems for managing blood glucose levels in type 1 diabetes, and one new clinical guideline.

On November 29, 2023, the French National Authority for Health (HAS) published an update of the methodological guide on the assignment of the HAS label to a good practice recommendation developed by a professional organization.

In November 2023, the National Institute for Health and Care Excellence (NICE) published four new Interventional Procedure Guidance (percutaneous thrombectomy for pulmonary embolism, percutaneous transarterial carotid artery stent placement for asymptomatic extracranial carotid stenosis, biodegradable subacromial spacer insertion for rotator cuff tears, extracorporeal carbon dioxide removal for acute respiratory failure) and one Health Technology Evaluation using early value assessment (virtual reality technologies for treating agoraphobia or agoraphobic avoidance). Also, five clinical guidelines were updated.

In October 2023, the National Institute for Health and Care Excellence (NICE) published two new Interventional Procedure Guidance (percutaneous deep venous arterialisation, vaginal transluminal endoscopic hysterectomy and adnexal surgery) and two Health Technology Evaluations using early value assessment (digital technologies for delivering specialist weight-management services, virtual ward platform technologies for acute respiratory infections). Also, one new clinical guideline was published, and eight were updated.

In September 2023, the National Institute for Health and Care Excellence (NICE) published three new Interventional Procedure Guidance (removal, preservation, and reimplantation of ovarian tissue for restoring fertility, transurethral water-jet ablation for lower urinary tract symptoms, cryotherapy for chronic rhinitis), and three Health Technology Evaluations using early value assessment (AI-derived software to analyze chest X-rays for suspected lung cancer, AI technologies to aid contouring for radiotherapy planning, KardiaMobile 6L for adults having antipsychotic medication). Also, two new clinical guidelines were published, and three were updated.

In August 2023, the National Institute for Health and Care Excellence (NICE) published one new Interventional Procedure Guidance (aortic valve reconstruction with glutaraldehyde-treated autologous pericardium for aortic valve disease) and one new Diagnostic Guidance (quantitative faecal immunochemical testing to guide colorectal cancer pathway referral in primary care). Also, five clinical guidelines were updated.

In June 2023, the National Institute for Health and Care Excellence (NICE) published one new Interventional Procedure Guidance (irreversible electroporation for treating prostate cancer) and one new Diagnostic Guidance (AI-derived computer-aided detection (CAD) software for detecting and measuring lung nodules in CT scan images). Also, three clinical guidelines were updated.

In June 2023, the National Institute for Health and Care Excellence (NICE) published five new Interventional Procedure Guidance (intraoperative electron beam radiotherapy, minimally invasive fusionless posterior-approach surgery to correct idiopathic scoliosis, endoscopic ultrasound-guided gallbladder drainage, radiofrequency denervation for osteoarthritic knee pain, and Botulinum toxin type A injections into the urethral sphincter), two new Diagnostic Guidance (transperineal biopsy for prostate cancer, and FibroScan for liver fibrosis and cirrhosis), and two Medtech Innovation Briefings (MiraQ cardiac TTFM, Proov Confirm; their development started before April 2023). Also, four clinical guidelines were updated.

In May 2023, the latest set of guidance (List 3) of the Evidence-based Interventions (EBI) Programme was published. The program is run by the Academy of Medical Royal Colleges (AoMRC), supported by NHS England and NICE. Ten procedures were added to the List across a range of medical specialties, including breast surgery, gastrointestinal surgery, cardiovascular, urology, and ophthalmology. It is expected that where treatment criteria outlined in the List for the intervention are met, it would be routinely funded.

In May 2023, the National Institute for Health and Care Excellence (NICE) published one new Interventional Procedure Guidance (intramuscular diaphragm stimulation for ventilator-dependent chronic respiratory failure from high spinal cord injuries), two new Diagnostic Guidance (MRI fusion biopsy systems for diagnosing prostate cancer, automated ankle-brachial pressure index measurement devices to detect peripheral arterial disease), and three new Health Technology Evaluations (Digitally enabled therapies for adults with anxiety disorders / with depression, and point-of-care tests for urinary tract infections). Also, four clinical guidelines were updated.

In April 2023, the National Institute for Health and Care Excellence (NICE) published seven new Interventional Procedure Guidance (concerned Daytime intraoral neuromuscular electrical tongue stimulation, endoscopic ultrasound-guided biliary drainage, maximal cytoreductive surgery in ovarian cancer, percutaneous thoracic duct embolization, radiofrequency ablation for spinal metastases, high-intensity focused ultrasound for prostate cancer), one new Medical Technologies Guidance (AposHealth for knee osteoarthritis), and one Medtech Innovation Briefing (Fasciotens for abdominal wall closure). Also, three clinical guidelines were updated.